International Scholarly Research Notices / 2011 / Article / Tab 3

Research Article

The Comparative Study of the Effectiveness of Cimetidine, Ranitidine, Famotidine, and Omeprazole in Treatment of Children with Dyspepsia

Table 3

Distribution of symptoms being relieved in relation to specific medication.

SymptomsPatientsDrugPatients before treatmentPercentage before treatmentPatients whom their symptoms relievedPercentage of whom their symptoms relieved 𝑃 -value*

Abdominal
pain
169Cimetidine3721.91745.9<.05
Famotidine3621.32466.7
Omeprazole5230.83873.1
Ranitidine44262965.9

Epigastric
pain
89Cimetidine2123.6628.6<.05
Famotidine1921.31368.4
Omeprazole3033.72066.7
Ranitidine1921.31368.4

Periumbilical pain95Cimetidine20211155>.05
Famotidine1717.91164
Omeprazole3132.62374
Ranitidine2728.51659

Nausea87Cimetidine20231890>.05
Famotidine13151184
Omeprazole33382987.8
Ranitidine21241780.9

Vomiting47Cimetidine1021.3990>.05
Famotidine817675
Omeprazole1736.21270.6
Ranitidine1225.51191.7

Anorexia87Cimetidine1820.7844.4>.05
Famotidine2427.61250
Omeprazole2427.61354.2
Ranitidine21241361.9

Early satiety54Cimetidine1527.81066.7>.05
Famotidine1222650
Omeprazole13241184.6
Ranitidine1425.6857.1

Heart burn39Cimetidine615.4350>.05
Famotidine820.5787.5
Omeprazole1948.71654.2
Ranitidine615.4583.3

Chest pain19Cimetidine526.3240>.05
Famotidine210.52100
Omeprazole842675
Ranitidine421375

Halitosis129Cimetidine2721725.9>.05
Famotidine2922.51344.8
Omeprazole40312152.5
Ranitidine3325.61751.5

Nocturnal awakening76Cimetidine1621956.3>.05
Famotidine1823.71477.7
Omeprazole2431.61875
Ranitidine1823.71372.2

* The 𝑃 -value is indicative of comparison between various medications effectiveness with each symptom relief.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.